University of Michigan Comprehensive Cancer Center SC — Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center SC is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Michigan Comprehensive Cancer Center SC has participated in 3 clinical trials.

Therapeutic areas: Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia, Advanced Solid Tumor.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan Comprehensive Cancer Center SC?

University of Michigan Comprehensive Cancer Center SC has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan Comprehensive Cancer Center SC conducted?

University of Michigan Comprehensive Cancer Center SC has 3 clinical trials on record. Their work covers Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia, Advanced Solid Tumor.

Is University of Michigan Comprehensive Cancer Center SC accredited by Crixeo Health?

University of Michigan Comprehensive Cancer Center SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan Comprehensive Cancer Center SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.